Sponsor Pipeline

Fei Li Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06700798 Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL： A Randomized… Marginal Zone Lymphoma(MZL) Recruiting
NCT06476899 A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib… CLL/SLL Not Yet Recruiting
Disease Areas
Chronic Lymphocytic Leukemia (CLL) (1)
Get alerts when Fei Li's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free